Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 2,921 shares at $31.34 ($90K) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Scheduled sale ($90k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.23 | 1,590 | $48K | 53.5% |
| 2 | $31.34 | 1,331 | $42K | 46.5% |
| Total | $30.74 avg | 2,921 | $90K | 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |